BiotechTube
Home/CSPC Pharmaceutical Group Limited/CAI Dongchen
CD

CAI Dongchen

Founder and Chairman of the Board

CSPC Pharmaceutical Group Limited

Roles

Founder and Chairman of the BoardatCSPC Pharmaceutical Group Limited
Chairman of CSPC Pharmaceutical GroupatCSPC Innovation Pharmaceutical

Therapeutic Areas

OncologyNervous SystemCardiovascular & MetabolicAnti-infectivesAutoimmune/Inflammatory

CSPC Pharmaceutical Group Limited Pipeline

DrugIndicationPhase
Envafolimab (CIPTRAMON)MSI-H/dMMR solid tumorsApproved
DPP-1 Inhibitor (CSPC-2231)Acute exacerbation of COPD, BronchiectasisPhase III
IL-17A/F Inhibitor (CSPC-2232)PsoriasisPhase III
ADC Candidate (CSPC-5018)Advanced solid tumorsPhase I/II
Nectin-4 ADC (CSPC-5092)Advanced solid tumorsPhase I
TROP2 ADC (CSPC-6024)Advanced solid tumorsPhase I
Claudin 18.2 ADC (CSPC-5902)Advanced solid tumorsPhase I

Leadership Team at CSPC Pharmaceutical Group Limited

CJ
CAI Jiang
Chief Executive Officer
ZL
ZHAO Li Ling
Vice President, Executive Director
ZJ
ZHANG Jingsong
Vice President
WQ
WANG Qingfeng
Vice President
LJ
LI Jian
Vice President
View full CSPC Pharmaceutical Group Limited profile